文献速递糖尿病

1型糖尿病合并微量白蛋白尿患者中抗衰老激素Klotho的扰动

Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria.
PubMed 文献 · Diabetologia · 2017-02-13

这项横断面单中心研究检测了33例有微量白蛋白尿史(使用RAS抑制剂)和45例无微量白蛋白尿史(未用RAS或其他降压药)的1型糖尿病患者的血清可溶性Klotho水平,发现有微量白蛋白尿者血清Klotho显著低于无微量白蛋白尿者,校正年龄和eGFR后差异持续存在。作者结论认为微量白蛋白尿与可溶性Klotho缺乏相关,需进一步研究确定因果关系。

要点

  • 1型糖尿病合并微量白蛋白尿者血清可溶性Klotho中位数659.3 pg/ml,低于无微量白蛋白尿者的787.7 pg/ml(p=0.023)。
  • 校正年龄和eGFR等变量后,两组血清Klotho差异持续存在。
  • 30例亚组中,其他磷平衡标志物在有无微量白蛋白尿者间无显著差异。

核心结论

  • 在1型糖尿病患者中,微量白蛋白尿与可溶性Klotho缺乏相关。
  • 需要进一步研究以确定可溶性Klotho是否与1型糖尿病中心肾疾病的发生存在因果关系。

研究设计与样本

  • 横断面单中心研究,纳入33例有微量白蛋白尿史(接受肾素-血管紧张素系统[RAS]抑制剂治疗)和45例无微量白蛋白尿史(未接受RAS或其他降压药)的1型糖尿病患者。
  • 所有参与者eGFR >45 ml/min、糖尿病病程 >20年且无心血管疾病史,血清可溶性Klotho用经过验证的免疫分析法测定。

主要发现

  • 有微量白蛋白尿者血清Klotho中位数(四分位距)为659.3(525.3,827.6),低于无微量白蛋白尿者的787.7(629.5,1007),p=0.023。
  • 校正包括年龄和eGFR在内的变量后,该差异持续存在。
  • 在30例有和无微量白蛋白尿者的亚组中,其他磷平衡标志物无显著差异。

局限性

  • 需要进一步研究以确定可溶性Klotho是否与1型糖尿病中心肾疾病的发生存在因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Patients with type 1 diabetes and microalbuminuria are at high risk of cardiovascular disease (CVD) and end-stage renal disease. Soluble Klotho is an anti-ageing circulating hormone involved in phosphate metabolism and vascular homeostasis through protective effects on the endothelium and antioxidant actions. The role of soluble Klotho in patients with type 1 diabetes and microalbuminuria is unknown. METHODS: In a cross-sectional single-centre study we evaluated the levels of circulating serum soluble Klotho in 33 participants with type 1 diabetes and a history of microalbuminuria (receiving renin-angiotensin system [RAS] inhibitors) and 45 participants with type 1 diabetes without a history of microalbuminuria (not receiving RAS or other antihypertensive drugs). All participants had an eGFR >45 ml/min, duration of diabetes >20 years and no history of CVD. Serum soluble Klotho levels were measured by a validated immunoassay. RESULTS: Participants with microalbuminuria had significantly lower levels of serum Klotho compared with those without microalbuminuria (median [interquartile range], 659.3 [525.3, 827.6] vs 787.7 [629.5, 1007]; p = 0.023). This difference persisted after adjustment for variables including age and eGFR. In a subgroup of 30 individuals with and without microalbuminuria, other markers of phosphate balance were not significantly different. CONCLUSIONS/INTERPRETATION: In individuals with type 1 diabetes, microalbuminuria is associated with soluble Klotho deficiency. Further studies are required to determine whether soluble Klotho is causally related to the development of cardio-renal disease in type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Maltese G, Fountoulakis N, Siow RC, et al. Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria. Diabetologia. 2017. PMID: 28194484. doi:10.1007/s00125-017-4219-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。